CONCERT PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Concert Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2021.
  • Concert Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was $0.000, a 100% decline year-over-year.
  • Concert Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $67.1M, a 27.7% decline from 2020.
  • Concert Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $92.9M, a 6299% increase from 2019.
  • Concert Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2019 was $1.45M.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $67.1M -$25.7M -27.7% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-03
2020 $92.9M +$91.4M +6299% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 $1.45M +$1.62M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 -$169K -$5.66M -103% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $5.49M +$4.89M +813% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-28
2016 $601K Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.